Skip to main content
. 2023 Jan 12;135(23-24):696–702. doi: 10.1007/s00508-022-02138-4

Table 1.

Baseline characteristics of the study population. Continuous variables are given as median (interquartile ranges in parentheses). Categorial variables are given as percentages and frequencies in parentheses. LVEF and renal function cut-offs were chosen according to EuroScore2 cut-offs

No frailty
(n = 112)
Frailty
(n = 127)
p-value
Age—years 80 (74–85) 85 (80–89) < 0.001
Male sex 44% (49) 42% (53) 0.75
Reason for hospitalization 0.912
Heart failure 50% (55) 50% (64)
Other cardiologic diseases 14% (15) 12% (15)
Other causes 37% (41) 38% (49)
Echocardiography
Mitral regurgitation 0.45
Moderate 71% (80) 67% (85)
Severe 29% (32) 33% (42)
Vena contracta—mm 6 (5–7) 6 (5–8) 0.39
LVEDD—mm 49 (42,5–57) 50 (44–59) 0.45
Left atrial size—cm2 28 (23–35) 30 (25–35) 0.61
LVEF 0.61
Preserved (≥ 50%) 46% (51) 43% (54)
Mildly reduced (41–49%) 25% (28) 22% (28)
Reduced (≤ 40%) 29% (33) 35% (45)
Aortic stenosis 0.98
Absent 81% (91) 79% (100)
Mild 5% (6) 6% (8)
Moderate 6% (7) 6% (8)
Severe 7% (8) 8% (10)
Comorbidities
EuroSCORE2 5.9% (6.4%) 6.8% (8.5%) 0.37
Coronary artery disease 33% (37) 22% (28) 0.057
Diabetes mellitus 17% (19) 24% (30) 0.20
Insulin-dependent 4% (4) 6% (8) 0.34
Atrial fibrillation 71% (79) 70% (89) 0.94
Extracardiac arteriopathy 22% (25) 35% (44) 0.036
Previous cardiac surgery 5% (6) 6% (7) 0.96
Chronic lung disease 16% (18) 15% (19) 0.81
NYHA classification 0.57
I 45% (50) 43% (55)
II 14% (16) 15% (19)
III 26% (29) 20% (26)
IV 15% (17) 21% (27)
CCS class 4 angina 5% (6) 6% (7) 0.96
Recent myocardial infarction—within 90 days 2% (2) 0% (0) 0.13
Renal function (GFR) 0.37
Normal (> 85 ml/min) 22% (25) 17% (21)
Moderately impaired (50–85 ml/min) 54% (60) 53% (67)
Severely impaired (< 50 ml/min) 24% (27) 31% (39)

CCS Canadian Cardiovascular Society, GFR glomerular filtration rate, LVEDD left ventricular end-diastolic diameter, LVEF left ventricular ejection fraction, PISA proximal isovelocity surface area